BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Vespasiani-Gentilucci U, Gallo P, Vincentis AD, Galati G, Picardi A. Hepatitis C virus and metabolic disorder interactions towards liver damage and atherosclerosis. World J Gastroenterol 2014; 20(11): 2825-2838 [PMID: 24659875 DOI: 10.3748/wjg.v20.i11.2825]
URL: https://www.wjgnet.com/1948-5182/full/v20/i11/2825.htm
Number Citing Articles
1
Hung-Yu Sun, Pin-Nan Cheng, Chiung-Ying Tseng, Wei-Jen Tsai, Yen-Cheng Chiu, Kung-Chia Young. Favouring modulation of circulating lipoproteins and lipid loading capacity by direct antiviral agents grazoprevir/elbasvir or ledipasvir/sofosbuvir treatment against chronic HCV infectionGut 2018; 67(7): 1342 doi: 10.1136/gutjnl-2017-313832
2
Rahul Chaudhari, Sherouk Fouda, Ashik Sainu, Joseph M Pappachan. Metabolic complications of hepatitis C virus infectionWorld Journal of Gastroenterology 2021; 27(13): 1267-1282 doi: 10.3748/wjg.v27.i13.1267
3
Umberto Vespasiani-Gentilucci, Chiara Dell’Unto, Antonio De Vincentis, Andrea Baiocchini, Marco Delle Monache, Roberto Cecere, Adriano Maria Pellicelli, Valerio Giannelli, Simone Carotti, Giovanni Galati, Paolo Gallo, Francesco Valentini, Franca Del Nonno, Davide Rosati, Sergio Morini, Raffaele Antonelli-Incalzi, Antonio Picardi. Combining Genetic Variants to Improve Risk Prediction for NAFLD and Its Progression to Cirrhosis: A Proof of Concept StudyCanadian Journal of Gastroenterology and Hepatology 2018; 2018: 1 doi: 10.1155/2018/7564835
4
Abdel Hady A. Abdel Wahab, Medhat S. El-Halawany, Ahmad A. Emam, Ammar Elfiky, Zakaria Y. Abd Elmageed. Identification of circulating protein biomarkers in patients with hepatocellular carcinoma concomitantly infected with chronic hepatitis C virusBiomarkers 2016; : 1 doi: 10.1080/1354750X.2016.1252966
5
Hui Cao, Xiaosong Chen, Zhijun Wang, Lei Wang, Qiang Xia, Wei Zhang. The role of MDM2–p53 axis dysfunction in the hepatocellular carcinoma transformationCell Death Discovery 2020; 6(1) doi: 10.1038/s41420-020-0287-y
6
Daniel Pineda-Tenor, Juan Berenguer, María A. Jiménez-Sousa, Ana Carrero, Mónica García-Álvarez, Teresa Aldámiz-Echevarria, Pilar García-Broncano, Cristina Diez, María Guzmán-Fulgencio, Amanda Fernández-Rodríguez, Salvador Resino. rs7903146 Polymorphism atTranscription Factor 7 Like 2Gene Is Associated with Total Cholesterol and Lipoprotein Profile in HIV/Hepatitis C Virus-Coinfected PatientsAIDS Research and Human Retroviruses 2015; 31(3): 326 doi: 10.1089/aid.2014.0195
7
Allison Cázares-Cortazar, Luis A. Uribe-Noguez, José Antonio Mata-Marín, Jesús Gaytán-Martínez, María de la Luz Martínez-Rodríguez, Pedro Esteban Villavicencio-Ferrel, Alberto Chapararro-Sánchez, Stefan Mauss, Alicia Ocaña-Mondragón. A decrease in hepatitis C virus RNA to undetectable levels in chronic hepatitis C patients after PegIFNα + RVB or sofosbuvir + NS5A inhibitor treatment is associated with decreased insulin resistance and persistent oxidative stressArchives of Virology 2020; 165(12): 2759 doi: 10.1007/s00705-020-04797-y
8
Beti Todorovska, Nenad Joksimovic, Viktorija Caloska-Ivanova, Magdalena Dimitrova-Genadieva, Meri Trajkovska, Elena Curakova, Sanja Kiprijanovska, Beti Zafirova-Ivanovska, Vladimir Serafimoski. Factors That Influence the Virological Response in Patients with Chronic Hepatitis C Treated with Pegylated Interferon and RibavirinPRILOZI 2017; 38(1): 25 doi: 10.1515/prilozi-2017-0003
9
Silvia Goñi Esarte, Regina Juanbeltz, José Manuel Zozaya, Juan Isidro Úriz, Jesús Castilla, José Ignacio Herrero. Modification of liver fibrosis, glucose and lipid profile after hepatitis C virus clearance with direct-acting antiviral agentsGastroenterología y Hepatología 2020; 43(5): 248 doi: 10.1016/j.gastrohep.2019.03.017
10
Abd Elkhalek Hamed, Medhat Elsahar, Nadia M. Elwan, Sarah El-Nakeep, Mervat Naguib, Hanan Hamed Soliman, Ashraf Ahmed Aboubakr, Amany AbdelMaqsod, Heba Sedrak, Samir N. Assaad, Reda Elwakil, Gamal Esmat, Samira Salh, Taymour Mostafa, Sherif Mogawer, Sameh Emil Sadek, Maha M. Saber, Hanan Ezelarab, Asem Ashraf Mahmoud, Souad Sultan, Mohamed El Kassas, Ehab Kamal, Naglaa M. ElSayed, Shorouk Moussa. Managing diabetes and liver disease association: Practice guidelines from the Egyptian Association for the Study of Liver and Gastrointestinal Disease (EASLGD)Arab Journal of Gastroenterology 2019; 20(1): 61 doi: 10.1016/j.ajg.2019.02.002
11
Seng Gee Lim, Alessio Aghemo, Pei-Jer Chen, Yock Young Dan, Edward Gane, Rino Gani, Robert G Gish, Richard Guan, Ji Dong Jia, Kieron Lim, Teerha Piratvisuth, Samir Shah, Mitchell L Shiffman, Frank Tacke, Soek Siam Tan, Tawesak Tanwandee, Khin Maung Win, Cihan Yurdaydin. Management of hepatitis C virus infection in the Asia-Pacific region: an updateThe Lancet Gastroenterology & Hepatology 2017; 2(1): 52 doi: 10.1016/S2468-1253(16)30080-2
12
Ming-Ling Chang, Yu-sheng Lin, Li-Heng Pao, Hsin-Chih Huang, Cheng-Tang Chiu. Link between plasminogen activator inhibitor-1 and cardiovascular risk in chronic hepatitis C after viral clearanceScientific Reports 2017; 7(1) doi: 10.1038/srep42503
13
Benli Jia, Dongsheng Yu, Gang Yu, Yunsheng Cheng, Yang Wang, Xiaoqiang Yi, Xiaoping Li, Yong Wang. Naringenin improve hepatitis C virus infection induced insulin resistance by increase PTEN expression via p53-dependent mannerBiomedicine & Pharmacotherapy 2018; 103: 746 doi: 10.1016/j.biopha.2018.04.110
14
Umberto Vespasiani-Gentilucci, Giovanni Galati, Paolo Gallo, Antonio De Vincentis, Elisabetta Riva, Antonio Picardi. Hepatitis C treatment in the elderly: New possibilities and controversies towards interferon-free regimensWorld Journal of Gastroenterology 2015; 21(24): 7412-7426 doi: 10.3748/wjg.v21.i24.7412
15
Javier Ampuero, Manuel Romero-Gómez. Assessing cardiovascular risk in hepatitis C: An unmet needWorld Journal of Hepatology 2015; 7(19): 2214-2219 doi: 10.4254/wjh.v7.i19.2214
16
Qi-tao Huang, Li-lin Hang, Mei Zhong, Yun-fei Gao, Man-ling Luo, Yan-hong Yu. Maternal HCV infection is associated with intrauterine fetal growth disturbanceMedicine 2016; 95(35): e4777 doi: 10.1097/MD.0000000000004777
17
Mubeen Khan Mohammed Abdul, Heather S. Snyder, Mythili Chunduru, Susan M.K. Lee, Sanjaya K. Satapathy. Hepatitis C Virus in the Elderly in the Direct-Acting Antiviral Era: from Diagnosis to CureCurrent Treatment Options in Infectious Diseases 2020; 12(3): 296 doi: 10.1007/s40506-020-00231-8
18
P. Pateria, G. P. Jeffrey, G. MacQuillan, D. Speers, H. Ching, M. A. Chinnaratha, G. F. Watts, L. A. Adams. The association between chronic hepatitis C infection and cardiovascular riskInternal Medicine Journal 2016; 46(1): 63 doi: 10.1111/imj.12936
19
Ting-ting Gao, Zhao-ling Qin, Hao Ren, Ping Zhao, Zhong-tian Qi. Inhibition of IRS-1 by hepatitis C virus infection leads to insulin resistance in a PTEN-dependent mannerVirology Journal 2015; 12(1) doi: 10.1186/s12985-015-0241-4
20
Q.-t. Huang, Q. Huang, M. Zhong, S.-s. Wei, W. Luo, F. Li, Y.-h. Yu. Chronic hepatitis C virus infection is associated with increased risk of preterm birth: a meta-analysis of observational studiesJournal of Viral Hepatitis 2015; 22(12): 1033 doi: 10.1111/jvh.12430
21
Antonio De Vincentis, Luisa Costanzo, Umberto Vespasiani-Gentilucci, Antonio Picardi, Stefania Bandinelli, Luigi Ferrucci, Raffaele Antonelli Incalzi, Claudio Pedone. Association between non-invasive liver fibrosis scores and occurrence of health adverse outcomes in older peopleDigestive and Liver Disease 2019; 51(9): 1330 doi: 10.1016/j.dld.2019.01.017
22
Sergio Salgüero, David Rojo, Juan Berenguer, Juan González‐García, Amanda Fernández‐Rodríguez, Oscar Brochado‐Kith, Cristina Díez, Victor Hontañon, Ana Virseda‐Berdices, Javier Martínez, Luis Ibañez‐Samaniego, Elba Llop‐Herrera, Coral Barbas, Salvador Resino, María A. Jiménez‐Sousa, Luis Ibáñez‐Samaniego, Leire Pérez‐Latorre, Diego Rincón, Teresa Aldámiz‐Echevarría, Vega Catalina, Pilar Miralles, Francisco Tejerina, María C Gómez‐Rico, Esther Alonso, José M Bellón, Rafael Bañares, José Arribas, José I Bernardino, Carmen Busca, Javier García‐Samaniego, Víctor Hontañón, Luz Martín‐Carbonero, Rafael Micán, María L Montes‐Ramírez, Victoria Moreno, Antonio Olveira, Ignacio Pérez‐Valero, Eulalia valencia, Juan González‐García, Elba Llop, José Luis Calleja, Agustín Albillos, Marta de Miguel, María Yllescas, Herminia Esteban. Plasma metabolomic fingerprint of advanced cirrhosis stages among HIV/HCV‐coinfected and HCV‐monoinfected patientsLiver International 2020; 40(9): 2215 doi: 10.1111/liv.14580
23
Abd Elkhalek Hamed, Medhat Elsahar, Nadia M. Elwan, Sarah El-Nakeep, Mervat Naguib, Hanan Hamed Soliman, Ashraf Ahmed Aboubakr, Amany AbdelMaqsod, Heba Sedrak, Samir N. Assaad, Reda Elwakil, Gamal Esmat, Samira Salh, Taymour Mostafa, Sherif Mogawer, Sameh Emil Sadek, Maha M. Saber, Hanan Ezelarab, Asem Ashraf Mahmoud, Souad Sultan, Mohamed El Kassas, Ehab Kamal, Naglaa M. ElSayed, Shorouk moussa. Managing diabetes and liver disease associationArab Journal of Gastroenterology 2018; 19(4): 166 doi: 10.1016/j.ajg.2018.08.003
24
Adriano M. Pellicelli, Valeria Pace Palitti, Pascal Vignally, Francesca Ceccherini‐Silberstein, Massimo Siciliano, Valerio Giannelli, Alessandra Moretti, Pierluigi Tarquini, Gaetano Scifo, Vincenzo Messina, Antonio Ascione, Antonio Izzi, Massimo Marignani, Cecilia D'Ambrosio, Lucia Fondacaro, Giuseppe M. Ettorre, Pasquale Ialongo, Rodolfo Sacco, Carlo F. Perno, Giorgio Barbarini, Lucia Miglioresi, Roberto Villani, Valeria Cento, Francesca W Chiesara, Loredana Alessio, Luca Fontanella, Barbara Imperatrice, Paola Begini, Giovanni Vennarecci, Angelo Barlattani, Orlando Armignacco, Francesco Di Candilo. Efficacy and safety of sofosbuvir/simeprevir plus flat dose ribavirin in genotype 1 elderly cirrhotic patients: A real‐life studyLiver International 2017; 37(5): 653 doi: 10.1111/liv.13288
25
Theodoros Voulgaris, Vassilios A. Sevastianos. Atherosclerosis as Extrahepatic Manifestation of Chronic Infection with Hepatitis C VirusHepatitis Research and Treatment 2016; 2016: 1 doi: 10.1155/2016/7629318
26
Ming-Ling Chang. Metabolic alterations and hepatitis C: From bench to bedsideWorld Journal of Gastroenterology 2016; 22(4): 1461-1476 doi: 10.3748/wjg.v22.i4.1461
27
Silvia Goñi Esarte, Regina Juanbeltz, José Manuel Zozaya, Juan Isidro Úriz, Jesús Castilla, José Ignacio Herrero. Modification of liver fibrosis, glucose and lipid profile after hepatitis C virus clearance with direct-acting antiviral agentsGastroenterología y Hepatología (English Edition) 2020; 43(5): 248 doi: 10.1016/j.gastre.2019.03.027
28
Tina M. St. John. Integrative Medicine2018; : 198 doi: 10.1016/B978-0-323-35868-2.00021-9